Edx Medical Group (LON:EDX) Shares Up 13.8% After Insider Buying Activity

Edx Medical Group (LON:EDX)’s stock price rose 13.8% during trading on Thursday after an insider bought additional shares in the company. The stock traded as high as GBX 7.50 and last traded at GBX 7.40. 148,517 shares were traded during mid-day trading, an increase of 108% from the average daily volume of 71,399 shares. The stock had previously closed at GBX 6.50.

Specifically, insider Michael Hudson purchased 25,000 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were purchased at an average cost of GBX 7 per share, with a total value of £1,750. Also, insider Michael Hudson acquired 75,000 shares of the business’s stock in a transaction dated Wednesday, November 4th. The shares were bought at an average cost of GBX 7 per share, for a total transaction of £5,250.

Edx Medical Group Stock Up 13.8%

The company has a fifty day moving average price of GBX 8.77. The company has a market capitalization of £31.92 million and a P/E ratio of -4.97.

Edx Medical Group (LON:EDX) last announced its quarterly earnings data on Thursday, September 3rd. The company reported GBX (1.50) earnings per share for the quarter.

Edx Medical Group Company Profile

EDX Medical Group plc is a United Kingdom-based medical diagnostics company focused on developing and commercializing clinical tests intended to support the detection, diagnosis and management of disease. Its work is centered on molecular and genetic testing, with an emphasis on providing more personalized information to healthcare professionals and patients.

The company’s activities include the development of diagnostic and screening products for applications such as cancer and other significant health conditions.